Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2024-12-18 00:00:00 ET · period of report 2024-12-16 · accession 0000950170-24-137889 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-12-18 | 2024-12-16 | CADL | Manning Paul B | Dir | P - Purchase | $6.00 | +1.25M | 1.30M | +2,325% | +$7.50M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-16 | P | A | 500,000 | $6.00 | 1,142,406 | I By Paul B. Manning Revocable Trust | — | — | (F1) The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| 2 | Common | Common Stock | 2024-12-16 | P | A | 750,000 | $6.00 | 1,303,752 | I By BKB Growth Investments, LLC | — | — | (F2) The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |